These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28115511)

  • 1. Predictive Role of Nighttime Blood Pressure in Response to Renal Denervation: Evidence From the DENER-HTN Study (Renal Denervation for Hypertension).
    Hering D
    Hypertension; 2017 Mar; 69(3):398-400. PubMed ID: 28115511
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
    Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
    Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL
    Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
    Gosse P; Cremer A; Pereira H; Bobrie G; Chatellier G; Chamontin B; Courand PY; Delsart P; Denolle T; Dourmap C; Ferrari E; Girerd X; Michel Halimi J; Herpin D; Lantelme P; Monge M; Mounier-Vehier C; Mourad JJ; Ormezzano O; Ribstein J; Rossignol P; Sapoval M; Vaïsse B; Zannad F; Azizi M
    Hypertension; 2017 Mar; 69(3):494-500. PubMed ID: 28115517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
    Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal denervation for uncontrolled hypertension: critical review of the evidence.
    Chen C; Upadhyay A
    Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):114-122. PubMed ID: 27922849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings.
    Esler M
    J Am Soc Hypertens; 2014 Aug; 8(8):593-8. PubMed ID: 25151320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.
    Sanghvi K; McGrew A; Hegde K
    Am Heart J; 2016 Oct; 180():e1-2. PubMed ID: 27659891
    [No Abstract]   [Full Text] [Related]  

  • 9. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
    Mauri L; Kario K; Basile J; Daemen J; Davies J; Kirtane AJ; Mahfoud F; Schmieder RE; Weber M; Nanto S; Azizi M
    Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal denervation: What happened, and why?
    Shishehbor MH; Hammad TA; Thomas G
    Cleve Clin J Med; 2017 Sep; 84(9):681-686. PubMed ID: 28885911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension.
    Ukena C; Mahfoud F; Kindermann I; Barth C; Lenski M; Kindermann M; Brandt MC; Hoppe UC; Krum H; Esler M; Sobotka PA; Böhm M
    J Am Coll Cardiol; 2011 Sep; 58(11):1176-82. PubMed ID: 21884958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications.
    Ewen S; Lauder L; Azizi M; Kandzari DE; Pathak A; Sharif F; Wijns W; Mahfoud F; Lüscher TF
    EuroIntervention; 2018 Aug; 14(5):e598-e602. PubMed ID: 29970353
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.
    ; Esler MD; Krum H; Sobotka PA; Schlaich MP; Schmieder RE; Böhm M
    Lancet; 2010 Dec; 376(9756):1903-9. PubMed ID: 21093036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Will SPYRAL HTN-OFF MED change my practice? SPYRAL HTN-OFF MED: a prospective, randomised, sham-controlled trial on renal denervation in the absence of antihypertensive medications.
    Lauder L; Ewen S; Azizi M; Mauri L; Lurz P; Lobo MD; Sharif F; Wijns W; Tsioufis C; Mahfoud F
    EuroIntervention; 2018 Aug; 14(5):e603-e606. PubMed ID: 29970354
    [No Abstract]   [Full Text] [Related]  

  • 15. Towards Establishing Renal Denervation as the Third Pillar in Hypertension Treatment: The RADIANCE-HTN TRIO Trial.
    Schlaich MP; Kiuchi MG; Carnagarin R
    Cardiovasc Intervent Radiol; 2021 Dec; 44(12):2015-2017. PubMed ID: 34523019
    [No Abstract]   [Full Text] [Related]  

  • 16. [Renal denervation 2013].
    Spinar J; Vítovec J; Spinarová L
    Vnitr Lek; 2013 Aug; 59(8):724-9. PubMed ID: 24007231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulse Wave Velocity Predicts Response to Renal Denervation in Isolated Systolic Hypertension.
    Fengler K; Rommel KP; Hoellriegel R; Blazek S; Besler C; Desch S; Schuler G; Linke A; Lurz P
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal denervation for hypertension: observations and predictions of a founder.
    Esler M
    Eur Heart J; 2014 May; 35(18):1178-85. PubMed ID: 24598982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal denervation for human hypertension: is there a future?
    Izzo JL; Tobe SW
    J Am Soc Hypertens; 2016 May; 10(5):390-2. PubMed ID: 27049792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistant hypertension in 2017.
    Hans S; Reilly JP
    Curr Opin Cardiol; 2017 Jul; 32(4):389-396. PubMed ID: 28505045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.